YVETTE MCLAURIN: Open Payments
NPI 1659891257 · CANTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,173 in 26 payments from 7 companies in 2025. Trend: 2023 $110 · 2024 $292 · 2025 $4,173
Travel & lodging: $3,574Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Midmark Corporation | 4 | $3,786 |
| ViiV Healthcare Company | 16 | $271 |
| Gilead Sciences, Inc. | 2 | $38 |
| Averitas Pharma Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: CABENUVA, QUTENZA, FREESTYLE LIBRE 3, PIFELTRO, MOUNJARO, DOVATO.
Industry payments across MS — which companies pay providers there.
